chrisvoncsefalvay/vaers-outcomes huggingface dataset:
It was probably around 7pm that evening that I started getting a headache and it got worse and worse as the evening went on. I went to bed and I was unable to sleep from 2AM onward and I took my temperature and by the time I went to get up for work my temperature was 101F. Throughout the day I had chills and fever and headache and body aches. It got slightly better around noon the day after my vaccine. I was able to eat and everything okay all day, I napped during the day because I felt crummy. Around 4:30PM my fever went up again above 101 so I had to call into work. I didn't take any medications at all, I just ate and drank water. By the time I went to bed my temperature was around 99 and then the next day my temperature it was normal most of the day. The day after that I was able to go back to work - I work in healthcare.
2 Days after vaccines, she developed fever, diarrhea and vomiting. Symptoms continued for 7-8 D. She had labwork & x-rays due to her age.
c/o rt shoulder, axilla, & deltoid aching & burning began few days p/1st vax; seen by MD dx rt shoulder pain unk etiology;p/3rd vax c/o pain bil elbows; seen by MD, good hand strength, nl reflexes, no muscle edema or atrophy;
pt recvd vax & w/in 24 hrs p/vax devel a fever of 103 & an inject site react which included hardness, welts & soreness; treatment included ice packs & APAP;
After vaccine was administered, patient reports pain in hand and veins look inflamed. Patient was directed to raise her arm. Patient reports not having anymore pain and veins look normal
MMR was administered to this child at age of three months. (MMR- Lot# 0497F)
pt recvd vax & 3-4 later exp flu-like sx; emesis lasted 3-4 days; nausea & weakness lasted approx 7 days;
Patient presented to the pharmacy the day following vaccination, she reported having soreness/redness at the injection site as well as pain in her neck, upper back, and wrist areas starting the evening of vaccination. When I examined the area on the day following vaccination the pain had subsided for her however there was still some redness around the injection site which looked like an injection site reaction. She was instructed to ice the area, take benadryl and to call/return if symptoms got worse or did not improve.
had a severe reaction, had to call a code and her heart stopped; This is a spontaneous report from a contactable consumer (Patient) via a Medical Information Team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection; Batch/Lot number: Not reported) via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. Medical history included shock her heart 5 times, Had reactions to IVP with contrast that has Iodine, allergic to sulfa antibiotics, acute renal failure, partial bowel blockage, renal insufficiency scared her right (ACE inhibitor and simvastatin works well and gives her lungs more protection), asthma and allergies. Concomitant medication were not reported. The patient previously took epinephrine and had reactions, bactrim and was allergic, flu shot and got sick in 2016. She can't have the contrast test. Had a severe reaction, had to call a code and her heart stopped on an unspecified date. Was put on IV and gave epinephrine and shock her heart 5 times. Called CDC and ask if there's any contraindication on getting the vaccine. Got a shot in 2016 and found out was getting sick from flu shot. Can't get flu shots anymore may be because egg content. Also had the Shingles vaccine had mild reactions to it took Benadryl and steroids and the follow up dose had to be pretreated because shingles break out. Reaction might be from the binders. Also took Versed and made her quit breathing and cannot get it. The outcome of the event was unknown.  Information on Lot/Batch has been requested.
very server night cramps in both legs after a very light workout that afternoon; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (very server night cramps in both legs after a very light workout that afternoon) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   On 28-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jun-2021, the patient experienced MUSCLE SPASMS (very server night cramps in both legs after a very light workout that afternoon). At the time of the report, MUSCLE SPASMS (very server night cramps in both legs after a very light workout that afternoon) outcome was unknown.            Concomitant medication details were not reported.  Treatment details were not provided.
Her arm is really achy, and she can't move; Her arm is really achy, and she can't move; aching all over but especially for her ankles and hands; experienced pain with her the outside of the leg on her left knee; feels like she is having a cold; feels cold and tired; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     The patient's past medical history included Renal disease and Knee surgery NOS.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MOBILITY DECREASED (Her arm is really achy, and she can't move) and ARTHRALGIA (experienced pain with her the outside of the leg on her left knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Whole body developed hives; Burning behind the backs of her knees and arms; Head and chest became itchy; Throat was tight; Throat swelled up; Triggered their eczema; This spontaneous case was reported by a health care professional and describes the occurrence of PHARYNGEAL SWELLING (Throat swelled up), ECZEMA (Triggered their eczema), URTICARIA (Whole body developed hives), BURNING SENSATION (Burning behind the backs of her knees and arms) and PRURITUS (Head and chest became itchy) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced PHARYNGEAL SWELLING (Throat swelled up) and ECZEMA (Triggered their eczema). On an unknown date, the patient experienced URTICARIA (Whole body developed hives), BURNING SENSATION (Burning behind the backs of her knees and arms), PRURITUS (Head and chest became itchy) and THROAT TIGHTNESS (Throat was tight). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form and CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) at a dose of UNK dosage form. At the time of the report, PHARYNGEAL SWELLING (Throat swelled up), ECZEMA (Triggered their eczema), URTICARIA (Whole body developed hives), BURNING SENSATION (Burning behind the backs of her knees and arms), PRURITUS (Head and chest became itchy) and THROAT TIGHTNESS (Throat was tight) outcome was unknown. Possible      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported. Treatment included cream.
devel high fever 1 hr following inject c/o soreness throughout body; fever lasted 3 days; periodic fever since;
12/15/22 presents to ED for "diarrhea""dehydration"  PMHx of "Diabetes mellitus, type II (CMS/HCC), DVT (deep venous thrombosis) (CMS/HCC) (1980), Dyslipidemia, Gout, Hypertension, Neuropathy"
Began experiencing irregular heartbeat; severe fatigue; This is a spontaneous report from a contactable consumer. A 56-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE), dose 2 via an unspecified route of administration in the left arm on 19Mar2021 (Lot Number: EN6204) as 2nd dose, single dose for covid-19 immunisation. Medical history included penicillin allergy. The patient was not diagnosed with covid-19 prior to vaccination. The patient received the first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE) dose 1 at vaccination age of 56-year-old via an unspecified route of administration in the left arm on 26Feb2021 (Lot Number: E6202) as 1st dose, single dose for covid-19 immunisation. The patient's concomitant medications were not reported. The patient received the vaccine in a hospital. The patient did not receive other vaccine in four weeks. On 01May2021, the patient began experiencing irregular heartbeat as well as experienced severe fatigue for about 4 weeks after second vaccine. The adverse events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events required treatment which included heart monitor and echocardiogram with medication. The patient underwent lab tests and procedures which included sars-cov-2 nasal swab was negative on Mar2021. The outcome of the events was not recovered.
This spontaneous report was received from a back office lead referring to a 20-year-old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 03-MAR-2016, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB lot # L035881, expiration date: 26-JUN-2017, 1 ml, intramuscularly, in left deltoid (a dose number was not provided). There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of 49 degrees Fahrenheit. This is one of several reports received from the same reporter. Additional information has been requested.
Weird pains for a few days - followed by major rash / blisters - still have significant pain  Diagnosed with shingles
Chills for 8 hours; Headache for 6 hours; Low grade fever for 6 hours; Arm soreness at injection site (non-debilitating) 1 day
doses administered past the published expiry date; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date). On 26-Oct-2021, EXPIRED PRODUCT ADMINISTERED (doses administered past the published expiry date) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were provided No treatment medications were provided
she felt like a truck came over her; her whole body ached; she had severe pain on her throat; very fatigued; slight fever; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (she felt like a truck came over her), PAIN (her whole body ached), OROPHARYNGEAL PAIN (she had severe pain on her throat), FATIGUE (very fatigued) and PYREXIA (slight fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 12-Mar-2021, the patient experienced DISCOMFORT (she felt like a truck came over her), PAIN (her whole body ached), OROPHARYNGEAL PAIN (she had severe pain on her throat), FATIGUE (very fatigued) and PYREXIA (slight fever). At the time of the report, DISCOMFORT (she felt like a truck came over her), PAIN (her whole body ached), OROPHARYNGEAL PAIN (she had severe pain on her throat), FATIGUE (very fatigued) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Bronchospasm 1.5 hours post injection relieved by 1 puff of albuterol. 12 hours post injection headache. 24 hours post injection chills, aches, malaise, low grade fever. Overall mild discomfort at the injection site.
PAIN IN THE ARMPIT; TIRED; HEADACHE; CHILLS; This spontaneous report received from a patient concerned a 55 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known allergies. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 07-MAY-2021, the subject experienced chills. On 08-MAY-2021, the subject experienced tired. On 08-MAY-2021, the subject experienced headache. On 09-MAY-2021, the subject experienced pain in the armpit. The action taken with covid-19 vaccine  was not applicable. The patient recovered from chills, tired, and headache, and had not recovered from pain in the armpit. This report was non-serious.
Patient was given a mixed series of the COVID vaccine. He did not experience any signs or symptoms of adverse reactions from the mixed series aside from a sore arm of the injection site.
pt recvd vax; devel rash; 20nov95 dx of chicken pox;
Received flu shot, covid and RSV in (L) deltoid. Reach to Employee health c/o itching, soreness swelling to (L) deltoid area. She states having all 3 vaccines in (L) deltoid. Influenza vaccine is the only provided by agency.
"bumps on lower back, hips, shoulders, under breasts, and vaginal area"; This case was reported by a consumer via call center representative and described the occurrence of generalized rash in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th November 2019, the patient received the 2nd dose of Shingrix. In November 2019, 2 weeks after receiving Shingrix, the patient experienced generalized rash. On an unknown date, the outcome of the generalized rash was unknown.   It was unknown if the reporter considered the generalized rash to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported. The patient 2 weeks after vaccination developed a rash on lower back, hips, shoulders, under breast, and in vaginal area. The patient did not consent to follow up. This case has been linked to US2019222795, reported by the same reporter.
Fever of 99 plus degrees that started evening of vaccination.   Felt "il" for 24 hours.  Three days after vaccination developed eye pain in right eye and flashes of light in right eye.  Flashes were worse upon waking and opening eyes.
Information has been received from a pharmacist referring to an unspecified number of patients of unknown age and gender. Information regarding concurrent conditions and medical history was not provided. Between 14-JUN-2015 and 14-JUL-2015, patients were vaccinated with doses of ZOSTAVAX that was improperly stored, lot # L011529, exp. date: 03-JUL-2016, 0.65 ml, subcutaneously (dose # and application site were not reported). Concomitant therapy was not reported. No adverse effects reported. Additional information has been requested.
Information has been received from a physician concerning his 12 month old grandson with no pertinent medical history and no drug reactions/allergies who on approximately 01-FEB-2006 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. On approximately 01-FEB-2006, since vaccination, the patient has had diarrhea on and off. On 07-FEB-2006, the patient experienced a blue coloring to his legs, arms, and lips with no dyspnea noted. this happened a few more time, very transient, lasting a few minutes. He also started with a fever of 103-104 axillary, and vomiting. He was noted to be taking fluids and has wet diapers. Unspecified medical attention was sought. He was treated with acetaminophen (TYLENOL). The outcome was reported as not recovered. No further information was available. It was noted that the caller did not know if the patient received other vaccinations with the measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live. No lab diagnostic studies were performed. There was no product quality complaint. Additional information has been requested.
Patient experienced hives and hot/cold flashes 2 hrs after receiving vaccine.  Later developed body aches and headache.
Onset of adverse reaction began on 10/25/14. Patient had an area of redness on her left inner arm. The site of the reaction was not on the site of injection. She did not complain of any pain or irritation.
Sudden bilateral hearing loss with pronounced tinnitus (sudden sensorineural hearing loss, SSNHL).
Patient was to receive 2nd dose of Varivax but mistakenly received Zostavax. CDC was contacted and informed us that Zostavax was ok for the second dose of Varivax and no further immunization would be necessary. Patient was made aware of the mix-up and was instructed to call the pharmacy if she experienced any adverse reaction as soon as possible. Pharmacy will continue following up with patient.
Pain in her legs; Feeling Tired; nausea; This case was reported by a consumer via call center representative and described the occurrence of leg pain in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 1st April 2019, the patient received the 1st dose of Shingrix. In April 2019, couple of days after receiving Shingrix, the patient experienced tiredness and nausea. In July 2019, the patient experienced leg pain. On an unknown date, the outcome of the leg pain was recovering/resolving and the outcome of the tiredness and nausea were resolved with sequelae.   It was unknown if the reporter considered the leg pain, tiredness and nausea to be related to Shingrix.  Additional details were provided as follows: The patient experienced pain in her legs but mostly her left leg. The pain was on the back of her legs and was worse at night. The patient also experienced feeling tired and had nausea. The patient consented to follow up.
Myalgia; Excruciating joint pain in both knees; Chills; HEADACHE; feeling tired; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Myalgia   ), VACCINATION SITE PAIN (Vaccination site pain), ARTHRALGIA (Excruciating joint pain in both knees), CHILLS (Chills) and FATIGUE (feeling tired) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis. Concomitant products included VITAMIN D NOS, MULTIVITAMIN [VITAMINS NOS], PROBIOTICS NOS and FISH OIL for an unknown indication.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (Vaccination site pain). On 07-Apr-2021, the patient experienced FATIGUE (feeling tired). On 20-Apr-2021, the patient experienced HEADACHE (HEADACHE). On 28-Apr-2021, the patient experienced CHILLS (Chills). On 06-May-2021, the patient experienced MYALGIA (Myalgia   ) and ARTHRALGIA (Excruciating joint pain in both knees). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 08-Apr-2021, VACCINATION SITE PAIN (Vaccination site pain) had resolved. On 11-May-2021, HEADACHE (HEADACHE) had resolved. At the time of the report, MYALGIA (Myalgia   ), ARTHRALGIA (Excruciating joint pain in both knees), CHILLS (Chills) and FATIGUE (feeling tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient used an ice pack for treatment.   This case was linked to MOD-2021-122507 (Patient Link).
I started having itching with raised whelped hives and a rash red spot on both legs, truck, arms, and face that gradually occurred over a few days. I seen my PCP and was put on Prednisone. I have also used topical creams for the itch. I just took my first dose of Prednisone this morning. I have also took Benadryl. It is somewhat better than a few days ago.
Patient had anaphylaxis with recorded trigger (Pfizer COVID vaccine). She received epinephrine onsite, and then an additional dose of  0.3mg in ED. She however, required required two more doses of 0.5mg epinephrine and racemic epi neb. She was admitted for further observation given need for multiple doses of epinephrine. At approximately 9:00 am (~18 hours post vaccine) a rapid response was called on 4/13 and patient was transferred to the PICU for further treatment.  Patient also received the last dose of epinephrine 0.5mg at approximately 9:00 am (~18 hours post vaccine). Patient received famotidine 20mg IV x1 and methylprednisolone 90mg IV x2 in the PICU. Patient was discharged on 4/14 at 8:00 am from the PICU, approximately 41 hours post vaccine administration. Received a total of epinephrine x7 doses during the hospitalization.
Information has been received from a health professional concerning a male with an unknown medical history who on 2/12/02 was vaccinated with a dose of varicella virus vaccine live (lot # 640090/1147L). It was unknown if the patient was on concomitant medication. Subsequently, the patient was seen in the office covered in chicken pox with more than 50 pox all over his body. No lab or other diagnostic studies were performed. It was also reported that there had been a serious outbreak of chicken pox in local schools. Unspecified medical attention was sought. It was also noted that three patients who are siblings were vaccinated with a dose of varicella virus vaccine live and developed chicken pox. Additional information has been requested.